Publication | Closed Access

A New Tacrine–Melatonin Hybrid Reduces Amyloid Burden and Behavioral Deficits in a Mouse Model of Alzheimer’s Disease

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineNeuropharmacologyDegenerative PathologyAlzheimer ’NeurologyNeuroscienceAging-associated DiseasePharmacologyNeurochemistryMouse ModelMelatoninBehavioral Deficits